|
|
|||||||||||
The British Journal of Psychiatry 174: 51-55 (1999)
© 1999 The Royal College of Psychiatrists
E Souetre, RM Thwaites and HL Yeardley
Pharmacoeconomic Research, Glaxo Wellcome Research & Development, Middlesex, UK.
BACKGROUND: While the costs associated with Alzheimer's disease have been shown to be significant, there are few data relating cost of care to severity of the disease. AIMS: We aimed to compare the costs associated with different severities of Alzheimer's disease with those incurred by control subjects over a three-month period. METHOD: In this cross-sectional, multicentre, naturalistic analysis, non- institutionalised patients with Alzheimer's disease (128), their care- givers (128), and 56 matched controls were interviewed once to establish resource use over the previous three months. Patients were stratified into three severity groups according to their Mini Mental State Examination score. Costs were calculated from the perspective of society as a whole. RESULTS: Over the three-month period, total mean cost per control subject (387 Pounds) was minor compared with mean cost incurred by patients with mild (6616 Pounds), moderate (10,250 Pounds) and severe (13,593 Pounds) Alzheimer's disease. Indirect cost, mainly time spent by care-givers, was the main cost component in all groups (68.6%), followed by direct medical costs (24.7%). CONCLUSIONS: The cost of care for an Alzheimer's disease patient is directly related to the severity of the patients illness.
This article has been cited by other articles:
![]() |
C. W. Zhu, N. Scarmeas, R. Torgan, M. Albert, J. Brandt, D. Blacker, M. Sano, and Y. Stern Longitudinal study of effects of patient characteristics on direct costs in Alzheimer disease Neurology, September 26, 2006; 67(6): 998 - 1005. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. W. Zhu, N. Scarmeas, R. Torgan, M. Albert, J. Brandt, D. Blacker, M. Sano, and Y. Stern Clinical features associated with costs in early AD: Baseline data from the Predictors Study Neurology, April 11, 2006; 66(7): 1021 - 1028. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. S. Bloom, N. de Pouvourville, and W. L. Straus Cost of Illness of Alzheimer's Disease: How Useful Are Current Estimates? Gerontologist, April 1, 2003; 43(2): 158 - 164. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. WOLSTENHOLME, P. FENN, A. M. GRAY, J. KEENE, R. JACOBY, and T. HOPE Estimating the relationship between disease progression and cost of care in dementia The British Journal of Psychiatry, July 1, 2002; 181(1): 36 - 42. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. T. Olin, I. R. Katz, B. S. Meyers, L. S. Schneider, and B. D. Lebowitz Provisional Diagnostic Criteria for Depression of Alzheimer Disease: Rationale and Background Am J Geriatr Psychiatry, April 1, 2002; 10(2): 129 - 141. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. KAVANAGH and M. KNAPP Costs and cognitive disability: modelling the underlying associations The British Journal of Psychiatry, February 1, 2002; 180(2): 120 - 125. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Fillenbaum, A. Heyman, B.L. Peterson, C.F. Pieper, and A.L. Weiman Use and cost of hospitalization of patients with AD by stage and living arrangement: CERAD XXI Neurology, January 23, 2001; 56(2): 201 - 206. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Psychiatric Bulletin | Advances in Psychiatric Treatment | All RCPsych Journals |